Daulton Varsho trade reported pending physical, Blue Jays outfielder reportedly sent for Arrighetti
Daulton Varsho trade reported pending a physical; the Blue Jays outfielder is reportedly exchanged for right‑hander Arrighetti. Performance and injury details.
Daulton Varsho has been reported as part of a trade that is pending a physical, according to multiple media reports, including an initial account from The Athletic’s Mitch Bannon. The move would send the 30‑year‑old outfielder away from Toronto in exchange for 26‑year‑old right‑hander Arrighetti. The Varsho trade has drawn attention because it pairs a veteran outfielder with notable power and defensive credentials against a young starter dealing with foot nerve irritation.
Deal Reported Pending Physical
Multiple outlets flagged the Varsho trade as official pending completion of a medical evaluation late in the reporting cycle. The Athletic’s Mitch Bannon was the first to publish the report, and subsequent social‑media posts amplified the development. Teams routinely condition trades on physicals to confirm that injured players meet expected health thresholds, and that step remains the final procedural hurdle here.
Neither club involved in the initial reports provided an official announcement at the time those accounts circulated. That leaves the transaction technically incomplete until the physical is cleared and paperwork is filed with the league. Sources also noted the potential for minor adjustments to the terms if medical examinations reveal new issues.
Varsho’s 2026 Offensive Snapshot
Varsho has experienced a quieter offensive campaign compared with earlier years, hitting .243 with a .682 OPS and seven home runs in the current season. Those numbers mark a downturn from some of his stronger power output seasons and have fueled speculation about Toronto’s willingness to move him. Analysts monitoring the Varsho trade highlighted the contrast between the current slippage and his established profile as a middle‑of‑the‑order contributor.
While this season’s counting stats lag, Varsho still carries a reputation as a power threat when healthy. Teams seeking immediate lineup impact often weigh recent form against track record, and the reported trade suggests the acquiring club was willing to bet on his ability to rebound.
Four Years in Toronto and Defensive Recognition
Since arriving in Toronto via a 2022 trade with the Arizona Diamondbacks, Varsho compiled a .226 batting average, a .719 OPS and 106 home runs across four seasons with the Blue Jays. Those aggregate figures reflect mixed results at the plate but consistent power production that made him a regular run producer in the middle of Toronto’s lineup. His tenure also included notable defensive work in the outfield.
Varsho’s defense was recognized with a Gold Glove award in 2024, the first of his career. That honor underscored his value above and beyond pure offensive output and factored into discussions around his overall worth. Teams valuing two‑way contributions likely considered that defensive pedigree when evaluating the Varsho trade.
Arrighetti’s Role and Recent Form
Arrighetti, the reported return in the Varsho trade, is a 26‑year‑old right‑handed starter currently on the injured list with right foot nerve irritation. When available this season, he produced a 4.60 ERA and a 1.34 WHIP across 88 innings, recording 87 strikeouts in 17 starts. Those numbers depict a pitcher capable of eating innings with strikeout potential but also one who has yielded baserunners at a middling clip.
Across his major‑league career, Arrighetti has logged a 4.66 ERA and a 1.386 WHIP in 53 appearances. The career metrics suggest he remains a work in progress, with flashes of competence balanced by inconsistency. Clubs that acquire young starters like Arrighetti often project mechanical adjustments or changes in usage might unlock better results.
Health Concerns Center on Foot Nerve Irritation
The most immediate variable in the reported swap is Arrighetti’s health, specifically the nerve irritation in his right foot that led to his placement on the injured list. Nerve issues can be unpredictable in recovery timelines and often require careful monitoring to ensure they do not recur under the stress of a starter’s workload. That medical uncertainty is the likely reason the trade is conditioned on a physical.
For the team acquiring Arrighetti, the physical will assess the severity and prognosis for the foot condition, including whether it could affect mechanics, velocity or long‑term durability. If the evaluation reveals manageable risk, the club may integrate him into its rotation plan; conversely, any red flags could prompt renegotiation or voiding of the deal.
Roster and Strategic Implications
If the Varsho trade clears the physical, the transaction will alter roster construction for both organizations involved. The Blue Jays’ reported move to part with a power outfielder could reflect a desire to bolster pitching depth or to address budget and roster flexibility. For the acquiring club, adding Varsho provides an experienced corner presence with proven power and elite defensive credentials in at least one season.
On the pitching side, Arrighetti presents a low‑cost rotation option with starter’s innings on his résumé. Teams often accept short‑term injury risk for the upside of a young arm that can be stabilized through coaching or workload management. The trade therefore appears to be an exchange of immediate offensive impact for potential pitching value down the road.
Closing thoughts on the matter center on the pending physical and how it will shape final outcomes; if cleared, the Varsho trade will represent a notable midseason roster move, while a failed exam could leave both clubs to revisit their plans.
